Losucon M 1/500 SR Tablet is used to treat type 2 diabetes mellitus; when diet, exercise, and glimepiride or metformin alone are not able to control the blood sugar levels.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
While on Losucon M 1/500 SR Tablet, avoid alcohol consumption. Alcohol can affect the blood sugar-lowering effects of the Losucon M 1/500 SR Tablet and increase the risk of lactic acidosis.
Losucon M 1/500 SR Tablet should not be taken during pregnancy. If you're planning to become pregnant, consult your doctor before considering Losucon M 1/500 SR Tablet.
Avoid taking Losucon M 1/500 SR Tablet during breastfeeding, as it can pass through breast milk. Consult your doctor for advice if you're considering Losucon M 1/500 SR Tablet while breastfeeding.
If you experience low or high blood sugar symptoms (like dizziness, tiredness, shaking, and trembling) or if altered blood sugar levels cause visual problems, refrain from driving or handling machinery.
Severe kidney disease patients should avoid Losucon M 1/500 SR Tablet. For those with kidney disease, caution is advised, and your dosage might need adjustment based on kidney function. Consult your doctor before using Losucon M 1/500 SR Tablet.
For severe liver disease patients, Losucon M 1/500 SR Tablet is not recommended. Patients with liver disease should use it cautiously, with dose adjustments as needed based on liver function. Consult your doctor before taking Losucon M 1/500 SR Tablet.
Losucon M 1/500 SR Tablet is used to regulate blood glucose levels. Its components, glimepiride, and metformin, have distinct mechanisms. Glimepiride boosts insulin secretion by the pancreas to decrease blood glucose. Metformin reduces liver glucose production, slows intestine glucose absorption, and enhances insulin sensitivity.
For individuals with type 2 diabetes mellitus, this medication is recommended as an adjunct to diet and exercise in the following scenarios:
Glimepiride is an anti-diabetic drug from the sulfonylurea class that lowers blood glucose levels. It primarily works by boosting insulin release from active pancreatic beta cells. It also enhances beta cell sensitivity to glucose, leading to increased insulin production. Additionally, Glimepiride might affect glucose absorption, peripheral tissue insulin sensitivity, and hepatic glucose production. A single dose of Glimepiride can provide a 24-hour hypoglycemic effect in non-fasting individuals with diabetes.
Metformin Hydrochloride, on the other hand, is an oral antihyperglycemic medication from the biguanide class. It's used for type 2 diabetes treatment. Unlike sulfonylureas, it doesn't cause hypoglycemia. Metformin reduces both basal and postprandial plasma glucose levels. It operates by reducing hepatic glucose synthesis, decreasing intestinal glucose absorption, and enhancing insulin sensitivity. This is achieved by increasing peripheral glucose uptake and utilization.
Drug-Drug Interaction: Glimepiride + Metformin could interact with various medications:
Drug-Food Interaction: Avoid alcohol consumption while on Glimepiride + Metformin. Combining them might raise the risk of lactic acidosis.
Drug-Disease Interaction: Inform your doctor if you have:
During Pregnancy:
Glimepiride: Pregnant individuals should avoid using Glimepiride as it could pose a risk to the fetus. Switching to insulin is recommended during pregnancy to ensure the safety of the unborn child. If planning to become pregnant, inform your doctor and discuss a suitable treatment plan.
Metformin: Metformin should not be used for diabetes treatment when planning to become pregnant or during pregnancy. Insulin is advised to maintain blood glucose levels as normal as possible, minimizing the risk of fetal malformations associated with abnormal blood sugar levels.
During Lactation:
Glimepiride: Breastfeeding mothers should avoid using Glimepiride to prevent the potential transfer of the medication to the infant through breast milk, which could be harmful. If needed, consider switching to insulin or discontinuing breastfeeding.
Metformin: Nursing rats secrete metformin in breast milk. While similar data in humans isn't conclusive, the decision to continue breastfeeding or discontinue it in favor of metformin should be made based on weighing the benefits of the medication for the mother against potential risks to the infant. Consult with a healthcare provider to make an informed decision.
For Glimepiride:
Initial Weeks and Hypoglycemia Risk: During the initial weeks of Glimepiride treatment, the risk of hypoglycemia (low blood sugar) may increase. Close monitoring is crucial during this period. If risk factors for hypoglycemia are present, dosage adjustments of Glimepiride or the entire treatment plan might be necessary. This holds true in cases of illness or significant lifestyle changes as well. While measures can initially control hypoglycemia, it's important to note that recurrence can happen.
Continuous Observation: Patients should remain under close observation, especially for severe hypoglycemia. Immediate treatment, medical follow-up, and potentially hospital care might be required.
G6PD-Deficiency Caution: Sulfonylurea agents, including Glimepiride, can lead to hemolytic anemia in patients with G6PD deficiency. Caution is advised in such cases, and non-sulfonylurea alternatives should be considered.
For Metformin:
Hypothyroidism Monitoring: Patients with hypothyroidism should have their thyroid-stimulating hormone (TSH) levels regularly checked during metformin therapy.
Vitamin B12 Levels: Prolonged metformin use can lead to decreased vitamin B12 levels, potentially causing peripheral neuropathy. Regular monitoring of vitamin B12 levels is recommended.
These precautions underscore the importance of close monitoring, particularly in the initial stages of Glimepiride treatment and during metformin therapy. Consult your healthcare provider if you have any concerns or experience any adverse effects.
Store at room temperature in a dry place. Protect it from direct sunlight and moisture. Keep it away from children and pets.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.